Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate

Condition:   Non-small Cell Lung Cancer Intervention:   Drug: donafenib tablets Sponsor:   First Affiliated Hospital of Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials